These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 21036726)
1. Isomorph expression of BAG-1 gene, ER and PR in endometrial cancer. Porichi O; Nikolaidou ME; Apostolaki A; Arnogiannaki N; Papassideri I; Chatonidis I; Tserkezoglou A; Vorgias G; Kassanos D; Panotopoulou E Anticancer Res; 2010 Oct; 30(10):4103-8. PubMed ID: 21036726 [TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875 [TBL] [Abstract][Full Text] [Related]
3. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma. Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655 [TBL] [Abstract][Full Text] [Related]
5. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer. Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443 [TBL] [Abstract][Full Text] [Related]
6. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study. Singh M; Zaino RJ; Filiaci VJ; Leslie KK Gynecol Oncol; 2007 Aug; 106(2):325-33. PubMed ID: 17532033 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study. Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247 [TBL] [Abstract][Full Text] [Related]
8. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression. Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977 [TBL] [Abstract][Full Text] [Related]
9. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer. Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778 [TBL] [Abstract][Full Text] [Related]
10. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Li SF; Shiozawa T; Nakayama K; Nikaido T; Fujii S Cancer; 1996 Jan; 77(2):321-9. PubMed ID: 8625241 [TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
12. Role of bcl-2 in endometrioid corpus cancer: an experimental study. Mariani A; Sebo TJ; Cliby WA; Keeney GL; Riehle DL; Lesnick TG; Podratz KC Anticancer Res; 2006; 26(2A):823-7. PubMed ID: 16619475 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma. Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672 [TBL] [Abstract][Full Text] [Related]
14. Expression of the epidermal growth factor system in endometrioid endometrial cancer. Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163 [TBL] [Abstract][Full Text] [Related]
15. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma. Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146 [TBL] [Abstract][Full Text] [Related]
16. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer. Yang YC; Wu CC; Chen CP; Chang CL; Wang KL Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591 [TBL] [Abstract][Full Text] [Related]